Legal Representation
Attorney
Richard L. Byrne, Registration No. 28,498
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-05-28)
Due Date
May 28, 2025
Grace Period Ends
November 28, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 28, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| May 28, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 12, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 12, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 20, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 7, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 7, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 7, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 3, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 29, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 30, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 30, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 30, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 29, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 17, 2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 16, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 10, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical, medical and veterinary preparations and articles, other than for immunoassays or in connection with immunoassays, namely, sulfated polysaccharides for pharmaceutical, medical, and veterinary use; pharmaceuticals, medical and veterinary preparations and articles containing polysaccharides for treatment of neurological diseases, disorders or conditions, for treating neuroinflammation, for treatment of fibrotic diseases, disorders or conditions, for treatment of ischemic diseases, disorders or conditions, for treatment of ophthalmic diseases, disorders or conditions
Additional Information
Design Mark
The mark consists of the wording "ILB" in a stylized font in black with a design of hearts in red. The color white represents background and is not claimed as a feature of the mark.
Color Claim
The color(s) red and black is/are claimed as a feature of the mark.
Classification
International Classes
005